---
title: "Cian Healthcare Ltd (542678) — Share Price, Financials & Analysis"
symbol: "542678"
company: "Cian Healthcare Ltd"
canonical: "https://tapetide.com/stocks/542678"
bse_code: "542678"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T19:10:08.582Z"
---

# Cian Healthcare Ltd (542678)

Canonical page: https://tapetide.com/stocks/542678

## Company

- **BSE Code:** 542678
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2019-05-23
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** cian.co

## About

Cian Healthcare Ltd is a BSE-SME listed pharmaceutical-formulations manufacturer 
with own /franchise brands, third-party manufacturing, institutional/government 
supply and exports. It makes tablets, capsules, soft-gels, liquid orals, ointments/creams, sachets and cosmetics across gynaecology, haematinic, cardio-diabetic, orthopaedic, paediatric, derma-cosmetic, antibiotic, CNS, vitamins and nutrients. The company exited CIRP under new promoter control in FY26[1]

## Latest Price

## Key Insights

### Strengths

- Company has reduced debt.
- Promoter holding has increased by 67.9% over last quarter.

### Weaknesses

- Stock is trading at 4.53 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -17.4% over past five years.
- Company has a low return on equity of -18.6% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 163 days.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 27% | — | — |
| revenue growth | -8% | -26% | -17% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 28 | 39 | 35 | 47 | 31 | 38 | 31 | 33 | 62 | 19 | 12 | 17 |
| Expenses | 23 | 34 | 28 | 44 | 30 | 32 | 24 | 28 | 51 | 20 | 17 | 20 |
| Operating Profit | 4 | 5 | 7 | 3 | 1 | 5 | 7 | 4 | 11 | -1 | -5 | -3 |
| OPM % | 15 | 13 | 20 | 7 | 2.9 | 14 | 22 | 14 | 18 | -8 | -44 | -18 |
| Other Income | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | -12 | 0 | -13 |
| Interest | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 6 | 2 | 1 | 0 |
| Depreciation | 3 | 2 | 1 | 2 | 2 | 3 | 3 | 3 | 5 | 2 | 2 | 2 |
| Profit before tax | -2 | -1 | 2 | -2 | -4 | 0 | 2 | -1 | 0 | -18 | -8 | -18 |
| Tax % | 17 | 23 | 28 | 7 | -13 | -167 | 14 | 37 | -400 | 0 | 0 | 0 |
| Net Profit | -2 | -1 | 1 | -2 | -4 | 0 | 2 | -1 | 0 | -18 | -8 | -18 |
| EPS in Rs | -0.75 | -0.46 | 0.48 | -0.72 | -1.54 | 0.19 | 0.62 | -0.59 | 0.1 | -7.3 | -3.09 | -7.19 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 57 | 74 | 78 | 69 | 62 | 31 | 28 |
| Expenses | 50 | 62 | 74 | 56 | 51 | 37 | 35 |
| Operating Profit | 7 | 12 | 4 | 13 | 11 | -7 | -7 |
| OPM % | 13 | 16 | 6 | 19 | 18 | -21 | -24 |
| Other Income | 1 | 0 | 0 | 1 | 0 | -12 | -12 |
| Interest | 7 | 8 | 7 | 6 | 6 | 3 | 0 |
| Depreciation | 4 | 3 | 4 | 5 | 5 | 4 | 4 |
| Profit before tax | -4 | 1 | -6 | 2 | 0 | -26 | -23 |
| Tax % | 7 | 91 | -8 | -2 | -1600 | 0 | 0 |
| Net Profit | -4 | 0 | -6 | 2 | 1 | -26 | -23 |
| EPS in Rs | -1.62 | 0.02 | -2.21 | 0.81 | 0.34 | -10.39 | -9.32 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 23 | 23 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 35 | 35 | 30 | 32 | 33 | 7 | -16 |
| Borrowings | 73 | 71 | 63 | 61 | 56 | 55 | 29 |
| Other Liabilities | 25 | 28 | 47 | 42 | 47 | 69 | 24 |
| Total Liabilities | 157 | 157 | 166 | 160 | 161 | 156 | 62 |
| Fixed Assets | 39 | 37 | 50 | 45 | 39 | 35 | 32 |
| CWIP | 25 | 26 | 13 | 14 | 15 | 15 | 6 |
| Investments | 5 | 5 | 5 | 5 | 5 | 5 | 0 |
| Other Assets | 87 | 90 | 98 | 97 | 102 | 101 | 23 |
| Total Assets | 157 | 157 | 166 | 160 | 161 | 156 | 62 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -7 | 6 | 9 | 5 | 12 | 21 | 21 |
| Cash from Investing Activity | -27 | 3 | 1 | 3 | -1 | 0 | 13 |
| Cash from Financing Activity | 36 | -10 | -11 | -7 | -10 | -4 | -50 |
| Net Cash Flow | 1 | -1 | -1 | 0 | 0 | 17 | -17 |
| Free Cash Flow | -26 | 4 | 4 | 4 | 11 | 20 | 29 |
| CFO/OP | -99 | 49 | 197 | 37 | 106 | -315 | -296 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 128 | 94 | 125 | 140 | 121 | 206 | 163 |
| Inventory Days | 214 | 277 | 300 | 400 | 486 | 420 | 82 |
| Days Payable | 176 | 186 | 270 | 296 | 371 | 671 | 219 |
| Cash Conversion Cycle | 166 | 185 | 155 | 244 | 236 | -45 | 26 |
| Working Capital Days | 15 | 16 | 38 | 41 | 26 | -729 | -96 |
| ROCE % | — | 7 | 0 | 7 | 5 | -11 | -16 |

## Shareholding Pattern

### annual

| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 70.89% | 70.89% | 66.26% | 51.85% | 27.1% | 27.11% | 95% |
| Public | 29.11% | 29.11% | 33.74% | 48.16% | 72.9% | 72.89% | 5% |
| No. of Shareholders | 326 | 361 | 392 | 454 | 880 | 1501 | 1683 |

### Quarterly

| Category | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 66.26% | 66.26% | 66.26% | 66.26% | 51.85% | 49.62% | 27.1% | 27.1% | 27.11% | 27.11% | 27.11% | 95% |
| DIIs | 0% | 0% | 0% | 0.79% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 33.74% | 33.74% | 33.75% | 32.96% | 48.16% | 50.39% | 72.9% | 72.9% | 72.9% | 72.89% | 72.89% | 5% |
| No. of Shareholders | 396 | 392 | 424 | 418 | 454 | 672 | 880 | 831 | 1088 | 1501 | 1662 | 1683 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 1 / 5

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 12.58 | Buy |
| EMA (10) | 12.71 | Buy |
| SMA (20) | 9.69 | Buy |
| EMA (20) | 10.7 | Buy |
| SMA (50) | 7.13 | Buy |
| EMA (50) | 8.24 | Buy |
| SMA (100) | 6.38 | Buy |
| EMA (100) | 6.85 | Buy |
| SMA (200) | 5 | Buy |
| EMA (200) | 6.24 | Buy |

### Oscillators — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 95.83 | Sell |
| MACD (12,26,9) | 2.3 | Buy |
| Stochastic (14,3,3) | 100 | Sell |
| ADX (14) | 65.25 | Buy |
| Williams %R (14) | 0 | Sell |
| ATR (14) | 0.49 | High Volatility |
| ROC (12) | 78.55 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 98.63 | Sell |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Manish Goswami appointed Chairperson for one year from March 16, 2026; KMPs authorised for materiality determinations. | [Granting Of Authorisation To Key Managerial Personnel For Determining The Materiality Of An Event Or Information Of The Company And Designate Mr. Manish Goswami As The Chairperson Of The Board ("Board") Of The Company. 9h - Manish Goswami appointed Chairperson for one year from March 16, 2026; KMPs authorised for materiality determinations.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d9289d2c-f951-4c6a-870d-e90ee4d1a78c.pdf) |
| 9h - Corporate office shifted to Ring Road Mall, Rohini, New Delhi effective March 16, 2026. | [Announcement under Regulation 30 (LODR)-Change in Corporate Office Address 9h - Corporate office shifted to Ring Road Mall, Rohini, New Delhi effective March 16, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4f27de8c-9724-4580-bf89-a2483d23eb9b.pdf) |
| 9h - Board approved revised Code for Fair Disclosure of UPSI, effective March 16, 2026. | [Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015 9h - Board approved revised Code for Fair Disclosure of UPSI, effective March 16, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b8aa1142-ee5a-4ff1-89dd-379483f4626c.pdf) |
| 9h - Board appointed Mr. Rachit Malhotra as Company Secretary and Chief Compliance Officer effective March 16, 2026. | [Appointment of Company Secretary and Compliance Officer 9h - Board appointed Mr. Rachit Malhotra as Company Secretary and Chief Compliance Officer effective March 16, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/860f612b-bcba-4032-98e1-3c1a08a18bf5.pdf) |
| 9h - Appointed Kalyani Chordia as CFO; Chirag Mehta Head-Operations; Ravikant Chavan IT-Head, effective March 16, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 9h - Appointed Kalyani Chordia as CFO; Chirag Mehta Head-Operations; Ravikant Chavan IT-Head, effective March 16, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9971d5cd-d1b1-4568-b7c0-027fd3ab7178.pdf) |
| 9 Feb - Committees constituted effective Feb 09, 2026 after NCLT-approved resolution; Pradeep Kumar Jain named director. | [Constitution Of Various Committees Of The Board Of The Company 9 Feb - Committees constituted effective Feb 09, 2026 after NCLT-approved resolution; Pradeep Kumar Jain named director.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e79b0ca9-cb84-4707-b7f9-ea5e6011d852.pdf) |
| 7 February 2026 - Siemens Energy orders ₹68,533,898.50 supply of LV cables for 220kV GIS Nepal; delivery by 30 April 2026. | [Bagging/Receiving of orders/contracts 7 February 2026 - Siemens Energy orders ₹68,533,898.50 supply of LV cables for 220kV GIS Nepal; delivery by 30 April 2026.](https://nsearchives.nseindia.com/corporate/PRIME2025_07022026135528_Order_Intimation.pdf) |
| 6 March 2026 - Submitted investor presentation for Arihant Bharat Connect Rising Stars conference; Feb 2026 presentation, includes H1FY26 financials and Q3 FY26 updates. | [Investor Presentation 6 March 2026 - Submitted investor presentation for Arihant Bharat Connect Rising Stars conference; Feb 2026 presentation, includes H1FY26 financials and Q3 FY26 updates.](https://nsearchives.nseindia.com/corporate/PRIME2025_06032026105152_PPT_MARCH_MEEETING.pdf) |
| 5h - BSE approved issuance of 2,37,50,000 shares to promoters and listing of 12,50,000 public shares (Mar 10, 2026). | [Update On The Receipt Of The In-Principle Approval In Relation To The Issuance Of 2,37,50,000 (Two Crores Thirty-Seven Lakhs Fifty Thousand) Fully Paid-Up Equity Shares At A Face Value Of INR 10/- (Indian Rupees Ten Only) Each, To The Prospective Promoters And Listing Approval For 12,50,000 (Twelve Lakhs Fifty Thousand) Fully Paid-Up Equity Shares At A Face Value Of INR 10/- (Indian Rupees Ten Only) Each To The Public Shareholders. 5h - BSE approved issuance of 2,37,50,00](https://www.bseindia.com/xml-data/corpfiling/AttachLive/98d70211-3eae-445e-8bd3-7c5977096648.pdf) |
| 5 Sep - Cian Healthcare dispatched 2025-26 AGM notice and annual report; AGM scheduled for September 29, 2026. | [Disclosure Regarding Dispatch Of Letters To Those Shareholders Whose Email Addresses Are Not Registered With The Company/ Registrar And Transfer Agent And Depository Participants. 5 Sep - Cian Healthcare dispatched 2025-26 AGM notice and annual report; AGM scheduled for September 29, 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad00aa4e-a767-46ca-ae5c-c8bff2bdfe67.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/PRIME2025_10112025105433_TRANSCRIPT_AND_LETTER.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/107ab704-828d-4dec-82c3-2a2b7dce3525.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2ac3b1f8-a9a4-46ed-b6ee-55b580f1d902.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5736b4ba-b67a-4c7c-b3be-f42c79f6fb26.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/542678/75690542678.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/542678/71732542678.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/542678/66418542678.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/542678/5426780319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/HIS_ANN_RPT/HISTANNR/2018/CIAN_HEALTHCARE_LTD-542678-MARCH-2018.PDF) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/HIS_ANN_RPT/HISTANNR/2017/CIAN_HEALTHCARE_LTD-542678-MARCH-2017.PDF) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/HIS_ANN_RPT/HISTANNR/2016/CIAN_HEALTHCARE_LTD-542678-MARCH-2016.PDF) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:10:08.582Z.